Hello, Fool! | Login | Signup | My Fool
Aug 29, 2008 12:33 AM ET | Site Changes | Help
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
View Ticker Page (VRTX)
Results 41 - 50 of 114 : 12345Next »
Recs
pjani06 (73.81) Submitted: 4/16/08 2:21 AM : Start Price: $25.87 VRTX Score: 8.25
In a climate where innovation has dried up, this company seems to deliver. Peers have been hit hard in this market climate however this one stood out and I believe for reason. Look for VRTX to lead long term.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
pshea12 (98.04) Submitted: 4/24/08 2:42 PM : Start Price: $25.16 VRTX Score: -15.16
Way too expensive. Its a good company, no doubt, but you will be paying heftily to be part of it. All of the upsides this stock offers cost too much and the potential for loss seems more probible than doing any better than it already is doing. Loo...
riloburnham (43.65) Submitted: 4/24/08 9:38 PM : Start Price: $24.85 VRTX Score: 16.46
Vertex Pharmaceuticals Inc. released more positive data on its hepatitis C drug candidate telaprevir. The has declined recentley making it a good buy.The stock fell $1.05, or 4.1 percent, to $24.90, adding to Wednesday's 3.8 percent decline. Shares...
YoungInvestor99 (22.44) Submitted: 5/06/08 8:08 PM : Start Price: $26.33 VRTX Score: 11.94
Rule breaker sept. 2007
marcd147 (97.73) Submitted: 5/17/08 10:09 PM : Start Price: $27.51 VRTX Score: 8.04
very interresting pipeline of drugs; currently leading they way in their niche
F4Phanatic (99.15) Submitted: 7/03/08 9:30 PM : Start Price: $34.04 VRTX Score: -22.49
Vertex Pharmaceuticals represents an attractive long-term opportunity based on the potential blockbluster sales of Telaprevir. Other potential pipeline candidates also look interesting, but Vertex is burning cash at a significant rate, thus frustrati...
Aquadoloop (44.44) Submitted: 7/17/08 4:57 PM : Start Price: $32.40 VRTX Score: -18.89
Up up and away. Great stock with great product.
highlandspring (< 20) Submitted: 7/29/08 11:20 PM : Start Price: $32.97 VRTX Score: -19.71
Promising new hepatitis C drug
jec00702 (53.23) Submitted: 7/31/08 12:08 PM : Start Price: $34.66 VRTX Score: -23.25
Don't I repeat Don't invest in biotechnology unless you have some kind of expertise in this field. There is a ton of mind numbing data which is generated from testing. You can't value these companies in the same manner you would a financial stock. ...
Budsworth (30.77) Submitted: 4/07/08 1:55 PM : Start Price: $26.28 VRTX Score: 9.40
This is the biggest news for millions of people carrying or suffering from Hepatitis C in years! The current treatments such as Roche's Pagasys, and other versions of the interferon are harsh treatments with a 14-16% rate of curing the disease. Verte...